Insider trades

Cormorant Global Healthcare Master Fund, 10% Owner of Bright Minds Biosciences DRUG, has filed 83 purchases and 24 sales on the open market. Over the past 12 months that comes to a net sale of $11.1M. The latest trade was on 04/28.

Cormorant Global Healthcare Master Fund

Former 10% Owner
First filing
23/03/16
Trades
111 trades
Buys / sales
83 / 24
12-month net buying
−$11.1M
Last trade
04/28

Trading activity

Transactions

Trade type
Open-market sale04/2804/30109,331 sh$89.50$9,785,124.5−10.3%
Open-market sale25/12/1125/12/1530,029 sh$11.46$344,132.34−1.3%
Open-market sale25/12/0425/12/0860,000 sh$15.70$942,000−0.7%
MLTX
Open-market sale25/09/29–25/09/3025/10/016,499,978 sh5 trades$7.21avg.$46,868,184.1−76.5%
Open-market sale25/05/1525/05/191,813,439 sh$1.85$3,354,862.15−100.0%
Open-market sale25/05/1225/05/1424,300 sh$1.99$48,357−1.3%
DRUG
Open-market buy24/10/15–24/10/1624/10/17422,591 sh11 trades$7.65avg.$3,234,153.96+93.4%
CRBP
Open-market buy24/09/2024/09/24350,000 sh6 trades$20.01avg.$7,004,060.33+17.3%
EYPT
Open-market buy24/05/0624/05/08850,000 sh2 trades$11.86avg.$10,081,720.98+11.4%
EYPT
Open-market buy24/04/1824/04/22581,765 sh2 trades$18.03avg.$10,489,446.18+8.4%
IMRX
Open-market sale24/04/0124/04/03400,000 sh8 trades$2.90avg.$1,160,182.5−12.1%
IMRX
Open-market sale24/03/14–24/03/1524/03/18909,091 sh5 trades$3.03avg.$2,750,627.69−21.6%
CRBP
Open-market buy24/03/07–24/03/0824/03/11550,000 sh10 trades$42.41avg.$23,327,559.6+37.3%
Open-market buy24/02/0224/02/06750,000 sh$19.00$14,250,000+103.4%
CRBP
Open-market buy24/01/2624/01/30282,632 sh14 trades$32.24avg.$9,111,940.74+63.9%
EYPT
Open-market buy24/01/09–24/01/1124/01/11855,000 sh2 trades$19.94avg.$17,051,100+14.2%
Open-market buy23/12/0823/12/12588,235 sh$17.00$9,999,995+10.8%
EYPT
Open-market buy23/12/0423/12/061,919,057 sh17 trades$21.82avg.$41,874,150.55+54.3%
Open-market buy23/10/2323/10/251,307,311 sh$6.99$9,138,103.89+13.2%
Open-market buy23/10/0523/10/1058,839 sh$59.90$3,524,456.1+0.7%